Anders Bladh

This profile gathers the share dealings of Anders Bladh across 2 companies, led by XSpray Pharma AB (publ) and DistIT AB. Between 5 September 2025 and 12 June 2026, the trades on record add up to 12 filings.

Market trades split into 5 purchases (€225k) and 3 sales (€213k). On balance, insiders were net buyers of €13k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2026, the count stands at 3 purchases and 2 sales.

In size, the median ticket on the buying side is €60k. 2 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 12 June 2026, reports an open-market purchase of €2,719 in XSpray Pharma AB (publ). Filings reach the Finansinspektionen feed a median of 2 days after the trade. The legal deadline for notifying a trade is three business days (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.